Document Detail

IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).
MedLine Citation:
PMID:  19411733     Owner:  NLM     Status:  MEDLINE    
Late stent malapposition (LSM) within a coronary artery aneurysm is an unusual intravascular ultrasound (IVUS) finding at follow up, and has been reported to be more common after drug-eluting stent implantation than after bare-metal stenting. We describe a case of LSM with coronary artery aneurysm 6 months after paclitaxeleluting stent implantation. This unusual case was successfully managed under IVUS guidance.
Charan P Lanjewar; Amit Sharma; Tej Sheth
Related Documents :
16399853 - Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-end...
11272363 - Pathology of radiation-induced coronary artery disease in human and pig.
8287463 - Technique for shortening angioplasty guide catheter length when therapeutic catheter fa...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of invasive cardiology     Volume:  21     ISSN:  1557-2501     ISO Abbreviation:  J Invasive Cardiol     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-04     Completed Date:  2009-09-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8917477     Medline TA:  J Invasive Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E87-90     Citation Subset:  IM    
Cardiology, Mumbai University, Seth G. S. Medical College and KEM Hospital, Mumbai, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina, Unstable / therapy,  ultrasonography
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects,  instrumentation,  methods*
Antineoplastic Agents, Phytogenic / administration & dosage
Coronary Aneurysm / therapy*,  ultrasonography
Coronary Restenosis / therapy*,  ultrasonography
Drug-Eluting Stents / adverse effects*
Equipment Failure
Follow-Up Studies
Middle Aged
Myocardial Infarction / therapy*
Paclitaxel / administration & dosage
Ultrasonography, Interventional*
Reg. No./Substance:
0/Antineoplastic Agents, Phytogenic; 33069-62-4/Paclitaxel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Percutaneous Revascularization of Chronic Total Occlusion of Left Anterior Descending Artery Using C...
Next Document:  An unusual complication of transradial coronary angiography.